Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · Real-Time Price · USD

11.37

-0.45 (-3.81%)

Mar 6, 2026, 12:51 PM EST - Market open

Elicio Therapeutics Employees

Elicio Therapeutics had 32 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

32

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,433,031

Market Cap

198.69M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	32	0	-
Dec 31, 2023	32	9	39.13%
Dec 31, 2022	23	-1	-4.17%
Dec 31, 2021	24	2	9.09%
Dec 31, 2020	22	-	-

Related Stocks

Company Name	Employees
Editas Medicine	246
Humacyte	220
Arcturus Therapeutics Holdings	176
Cibus	159
Heron Therapeutics	128
Cartesian Therapeutics	66
Acumen Pharmaceuticals	61
Camp4 Therapeutics	55

Employee Rankings

ELTX News

9 days ago - Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
16 days ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
3 months ago - Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial - GlobeNewsWire
3 months ago - Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer - GlobeNewsWire
4 months ago - Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
4 months ago - Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent - Seeking Alpha
4 months ago - Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC - GlobeNewsWire
4 months ago - Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting - GlobeNewsWire